Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -150,697 | -72,865 | -276,011 | -203,350 | -137,569 |
| Depreciation Amortization | 551 | 277 | 1,149 | 565 | 455 |
| Accounts receivable | 0 | N/A | N/A | N/A | -1,179 |
| Accounts payable and accrued liabilities | 4,479 | 3,935 | 2,231 | 3,075 | 6,821 |
| Other Working Capital | 11,470 | 6,782 | 12,543 | 10,701 | 9,672 |
| Other Operating Activity | 52,243 | 25,829 | 118,398 | 88,280 | 55,962 |
| Operating Cash Flow | $-81,954 | $-36,042 | $-141,690 | $-100,729 | $-65,838 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -124 | -7,284 | -6,727 | -6,662 |
| Purchase Of Investment | -79,513 | -79,728 | -81,794 | -81,794 | -62,727 |
| Sale Of Investment | 43,650 | 25,779 | 231,267 | 209,874 | 161,274 |
| Other Investing Activity | 1 | 0 | 0 | -3 | -2 |
| Investing Cash Flow | $-35,994 | $-54,073 | $142,189 | $121,350 | $91,883 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,271 | 706 | 162,430 | 351 | 222 |
| Financing Cash Flow | $4,271 | $706 | $162,430 | $351 | $222 |
| Beginning Cash Position | 198,811 | 198,811 | 35,882 | 31,569 | 31,569 |
| End Cash Position | 85,134 | 109,402 | 198,811 | 52,541 | 57,836 |
| Net Cash Flow | $-113,677 | $-89,409 | $162,929 | $20,972 | $26,267 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,954 | -36,042 | -141,690 | -100,729 | -65,838 |
| Capital Expenditure | -132 | -124 | -7,284 | -6,727 | -6,662 |
| Free Cash Flow | -82,086 | -36,166 | -148,974 | -107,456 | -72,500 |